decrease of Baht 56 million or a decrease of 14% compared to that of the previous year amounting to Baht 394 million. The decline was mainly due to the relocation of the production base of a former large
10.59% QoQ resulting from improving in production capability, efficiency and fuel management. Cost to revenue from sale of industrial equipment ratio in Q1-2020 decreased by 13.56% QoQ resulting from
impairment of intangible assets - - 16.87 28.57 Loss from impairment finance costs and share of loss from associates 29.81 216.80 - - Doubtful Account 88.24 641.75 - - Loss from impairment of goodwill 51.20
of the acquisition of Modern Pharma Company Limited Board of Directors' opinion The meeting of shareholders should consider approving to expand the business to cover the production of human and animals
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
PUBLIC COMPANY LIMITED PTT EXPLORATION AND PRODUCTION PUBLIC COMPANY LIMITED PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED PTT OIL AND RETAIL BUSINESS PUBLIC COMPANY LIMITED PTT PUBLIC COMPANY LIMITED PYLON
investments in new machineries for replacements and a launch of the production automation under the scheme of Delta Smart Manufacturing. The company believes that it would be a key factor for the
Gross Profit Margin (%) 69.78 69.35 Note: /1 Other costs of goods sold mainly comprise warehouse rentals, utility charges and other expenses related to production. Gross Profit Gross profit for the period
) (19.89%) 710.90 580.63 (130.27) (18.32%) Earnings per share (EPS) 0.21 0.17 (0.04) (19.89%) 0.43 0.35 (0.08) (18.32%) Note: 1) Revenue and Cost that were recognized when there is construction under
labor cost and raw materials since the 2nd quarter of this year. Even though this resulted in the Company had the production cost and the cost of goods sold increased, but this policy would finally help